152 related articles for article (PubMed ID: 30604097)
1. Altered brain arginine metabolism in a mouse model of tauopathy.
Vemula P; Jing Y; Zhang H; Hunt JB; Sandusky-Beltran LA; Lee DC; Liu P
Amino Acids; 2019 Mar; 51(3):513-528. PubMed ID: 30604097
[TBL] [Abstract][Full Text] [Related]
2. Altered Brain Arginine Metabolism and Polyamine System in a P301S Tauopathy Mouse Model: A Time-Course Study.
Mein H; Jing Y; Ahmad F; Zhang H; Liu P
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682712
[TBL] [Abstract][Full Text] [Related]
3. Altered brain arginine metabolism with age in the APP
Vemula PK; Jing Y; Cicolini J; Zhang H; Mockett BG; Abraham WC; Liu P
Neurochem Int; 2020 Nov; 140():104798. PubMed ID: 32711019
[TBL] [Abstract][Full Text] [Related]
4. Altered arginine metabolism in Alzheimer's disease brains.
Liu P; Fleete MS; Jing Y; Collie ND; Curtis MA; Waldvogel HJ; Faull RL; Abraham WC; Zhang H
Neurobiol Aging; 2014 Sep; 35(9):1992-2003. PubMed ID: 24746363
[TBL] [Abstract][Full Text] [Related]
5. A single intracerebroventricular Aβ25-35 infusion leads to prolonged alterations in arginine metabolism in the rat hippocampus and prefrontal cortex.
Bergin DH; Jing Y; Zhang H; Liu P
Neuroscience; 2015 Jul; 298():367-79. PubMed ID: 25907447
[TBL] [Abstract][Full Text] [Related]
6. Behavioural Functions and Cerebral Blood Flow in a P301S Tauopathy Mouse Model: A Time-Course Study.
Ahmad F; Mein H; Jing Y; Zhang H; Liu P
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575885
[TBL] [Abstract][Full Text] [Related]
7. BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT
Perez-Garcia G; Bicak M; Haure-Mirande JV; Perez GM; Otero-Pagan A; Gama Sosa MA; De Gasperi R; Sano M; Barlow C; Gage FH; Readhead B; Ehrlich ME; Gandy S; Elder GA
Neurosci Lett; 2023 Feb; 797():137080. PubMed ID: 36657633
[TBL] [Abstract][Full Text] [Related]
8. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
9. Spermidine/spermine-N
Sandusky-Beltran LA; Kovalenko A; Ma C; Calahatian JIT; Placides DS; Watler MD; Hunt JB; Darling AL; Baker JD; Blair LJ; Martin MD; Fontaine SN; Dickey CA; Lussier AL; Weeber EJ; Selenica MB; Nash KR; Gordon MN; Morgan D; Lee DC
Alzheimers Res Ther; 2019 Jun; 11(1):58. PubMed ID: 31253191
[TBL] [Abstract][Full Text] [Related]
10. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
11. Effects of maternal immune activation on brain arginine metabolism of postnatal day 2 rat offspring.
Zhang J; Jing Y; Zhang H; Bilkey DK; Liu P
Schizophr Res; 2018 Feb; 192():431-441. PubMed ID: 28526281
[TBL] [Abstract][Full Text] [Related]
12. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
13. In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy.
Crescenzi R; DeBrosse C; Nanga RP; Reddy S; Haris M; Hariharan H; Iba M; Lee VM; Detre JA; Borthakur A; Reddy R
Neuroimage; 2014 Nov; 101():185-92. PubMed ID: 25003815
[TBL] [Abstract][Full Text] [Related]
14. Altered brain arginine metabolism in schizophrenia.
Liu P; Jing Y; Collie ND; Dean B; Bilkey DK; Zhang H
Transl Psychiatry; 2016 Aug; 6(8):e871. PubMed ID: 27529679
[TBL] [Abstract][Full Text] [Related]
15. Scopolamine impairs behavioural function and arginine metabolism in the rat dentate gyrus.
Knox LT; Jing Y; Fleete MS; Collie ND; Zhang H; Liu P
Neuropharmacology; 2011 Dec; 61(8):1452-62. PubMed ID: 21903106
[TBL] [Abstract][Full Text] [Related]
16. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
[TBL] [Abstract][Full Text] [Related]
17. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy.
Vagnozzi AN; Giannopoulos PF; Praticò D
Transl Psychiatry; 2017 Dec; 7(12):1288. PubMed ID: 29249809
[TBL] [Abstract][Full Text] [Related]
18. Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice.
Walker CK; Greathouse KM; Boros BD; Poovey EH; Clearman KR; Ramdas R; Muhammad HM; Herskowitz JH
Neuroscience; 2021 Feb; 455():195-211. PubMed ID: 33346120
[TBL] [Abstract][Full Text] [Related]
19. Sustained Arginase 1 Expression Modulates Pathological Tau Deposits in a Mouse Model of Tauopathy.
Hunt JB; Nash KR; Placides D; Moran P; Selenica ML; Abuqalbeen F; Ratnasamy K; Slouha N; Rodriguez-Ospina S; Savlia M; Ranaweera Y; Reid P; Dickey CA; Uricia R; Yang CG; Sandusky LA; Gordon MN; Morgan D; Lee DC
J Neurosci; 2015 Nov; 35(44):14842-60. PubMed ID: 26538654
[TBL] [Abstract][Full Text] [Related]
20. Age-related changes in arginine and its metabolites in memory-associated brain structures.
Liu P; Jing Y; Zhang H
Neuroscience; 2009 Dec; 164(2):611-28. PubMed ID: 19699269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
